![Jennifer Cook Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jennifer Cook Williams
Corporate Officer/Principal at Cook Williams Communications, Inc.
Network origin in Jennifer Cook Williams first degree
Entity | Entity type | Industry | |
---|---|---|---|
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer.
28
| Extinct | Pharmaceuticals: Major | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jennifer Cook Williams via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Genetics Institute LLC
![]() Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
SEQUUS Pharmaceuticals, Inc.
![]() SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer General Counsel | |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ViaCyte, Inc.
![]() ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ceregene, Inc.
![]() Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Virginia | College/University | Undergraduate Degree Corporate Officer/Principal | |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member Private Equity Investor | |
Dartmouth College | College/University | Undergraduate Degree Doctorate Degree | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
SANOFI INDIA LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BLUEBIRD BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
The Ohio State University
![]() The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Graduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
Intracel Holdings Corp.
![]() Intracel Holdings Corp. BiotechnologyHealth Technology Intracel Holdings Corp. engages in the development of vaccines and diagnostic products for cancer and infectious diseases. The company was founded in 2013 and is headquartered in Frederick, MD. | Biotechnology | Chief Executive Officer | |
Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
National Academy of Sciences
![]() National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
National Academy of Medicine (United States)
![]() National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Philosophical Society
![]() American Philosophical Society Miscellaneous Commercial ServicesCommercial Services The American Philosophical Society is an organization that hosts biannual general meetings for its members, families, and distinguished guests. The non-profit company is based in Philadelphia, PA. The meetings cater to the diverse interests and expertise of attendees and provide a unique opportunity to indulge the audience’s breadth of intellectual curiosity. The society has an exceptional collection of over 13 million manuscripts, objects, books, images, and works of art covering various topics such as early and revolutionary history, natural history, Indian linguistics and culture, nuclear physics, computer development, medical science, genetics and eugenics, and the development of cultural anthropology. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Calimmune, Inc.
![]() Calimmune, Inc. BiotechnologyHealth Technology Calimmune, Inc. operates as a clinical-stage biotechnology company. The firm offers Cal-1, a gene-based stem cell therapy to protect individuals infected with HIV from progressing to AIDS. The company was founded by David Baltimore, Inder M. Verma, Irvin Chen and Louis Breton in 2006 and is headquartered in Tucson, AZ. | Biotechnology | Chairman Founder | |
KITE PHARMA INC | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
CANDEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder | |
ONCORUS, INC. | Biotechnology | Chief Executive Officer | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
CODA Biotherapeutics, Inc.
![]() CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA. | Medical Specialties | Founder | |
California Life Sciences Association
![]() California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ElevateBio LLC
![]() ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
Elevatebio Base Camp, Inc. | President | ||
TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
Abata Therapeutics, Inc.
![]() Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer. | Biotechnology | Director/Board Member | |
LifeEDIT Therapeutics, Inc.
![]() LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
Tabby Therapeutics Ltd.
![]() Tabby Therapeutics Ltd. BiotechnologyHealth Technology Tabby Therapeutics Ltd. develops therapeutic drugs. The company is based in Ness Ziona, Israel. The Israeli company was founded in 2021 by Adi Barzel, Alessio D. Nahmad. | Biotechnology | Director/Board Member | |
Semma Therapeutics, Inc.
![]() Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member |
Statistics
International
United States | 48 |
Israel | 3 |
India | 2 |
Sectoral
Health Technology | 35 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 3 |
Operational
Director/Board Member | 116 |
Corporate Officer/Principal | 71 |
Chief Tech/Sci/R&D Officer | 33 |
Independent Dir/Board Member | 32 |
President | 23 |
Most connected contacts
Insiders | |
---|---|
Mitchell Finer | 26 |
R. Greer | 23 |
Thomas Shenk | 21 |
John T. Potts | 18 |
Kristen Hege | 17 |
Inder Mohan Verma | 17 |
Aya Jakobovits | 16 |
Dennis L. Winger | 15 |
James McArthur | 15 |
Daniel F. Hoth | 14 |
David Warren Carter | 13 |
Natalie Sacks | 13 |
Lesley A. Stolz | 12 |
Jeffrey Steven Silverman | 10 |
John J. Schembri | 10 |
- Stock Market
- Insiders
- Jennifer Cook Williams
- Company connections